CLINICAL_TRIALS
trial_result
· 2017-02-28
Clinical Trial Update: CRT-Guanfacine for SPD [Phase 2]
Summary
A Phase 2 trial investigating CRT-Guanfacine for Schizotypal Personality Disorder has completed; the update does not include results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Schizotypal Personality Disorder, SPD | Phase 2 | Status: COMPLETED